Innate immune signals modulate antiviral and polyreactive antibody responses during severe respiratory syncytial virus infection

Journal of Infectious Diseases

Volumn 199, Issue 8, 2009, Pages 1128-1138

  Reed, Jennifer L ^a   Welliver, Timothy P ^b,f   Sims, Gary P ^b   McKinney, LuAnn ^b   Velozo, Luis ^d   Avendano, Luis ^e   Hintz, Karen ^c   Luma, Jayson ^c   Coyle, Anthony J ^b   Welliver, Robert C ^c  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Respiratory Inflammation and Autoimmunity Group ^*  (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d HOSPITAL ROBERTO DEL RÍO   (Chile)

^e UNIVERSITY OF CHILE   (Chile)

^f UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; CD20 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON; INTERLEUKIN 4; VIRUS ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; INFANT; INNATE IMMUNITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRAL BRONCHIOLITIS; VIRUS INFECTION;

ANTIBODIES, VIRAL; B-LYMPHOCYTES; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULINS; INFANT; LUNG; OXYGEN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 65649091691     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597386     Document Type: Article

References (50)

1. Greenough A, Cox S, Alexander J, et al.Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection. Arch Dis Child 2001; 85:463-8.
2. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003; 143(5 Suppl): S127-32.
3. Garenne M, Ronsmans C, Campbell H. The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries. World Health Stat Q 1992; 45:180-91.
4. Perez-Yarza EG, Moreno A, Lazaro P, Mejias A, Ramilo O. The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature. Pediatr Infect Dis J 2007; 26:733-9.
5. van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N, Kovacs- Nolan J. Immunopathology of RSV infection: prospects for developing vaccines without this complication. Rev Med Virol 2007; 17:5-34.
6. Gimenez HB, Keir HM, Cash P. Immunoblot analysis of the human antibody response to respiratory syncytial virus infection. J Gen Virol 1987; 68:1267-75.
7. McIntosh K, Masters HB, Orr I, Chao RK, Barkin RM. The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis 1978; 138:24-32.
8. Murphy BR, Graham BS, Prince GA, et al.Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol 1986; 23:1009-14.
9. Brandenburg AH, Groen J, van Steensel-Moll HA, et al.Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection. J Med Virol 1997; 52: 97-104.
10. Ogilvie MM, Vathenen AS, Radford M, Codd J, Key S. Maternal antibody and respiratory syncytial virus infection in infancy. J Med Virol 1981; 7:263-71.
11. Ruuskanen O, Ogra PL. Respiratory syncytial virus. Curr Probl Pediatr 1993; 23:50-79.
12. Hall CB, Walsh EE, Long CE, Schnabel KC. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 1991; 163: 693-8.
13. Graham BS, Johnson TR, Peebles RS. Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology 2000; 48:237-47.
14. Kim HW, Leikin SL, Arrobio J, Brandt CD, Chanock RM, Parrott RH. Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection. Pediatr Res 1976; 10:75-8.
15. Welliver TP, Garofalo RP, Hosakote Y, et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 2007; 195:1126-36.
16. + T cell-B cell collaboration. J Immunol 2007; 179:5886-96.
17. Meurman O, Ruuskanen O, Sarkkinen H, Hanninen P, Halonen P. Immunoglobulin class-specific antibody response in respiratory syncytial virus infection measured by enzyme immunoassay. J Med Virol 1984; 14:67-72.
18. Lamm ME. Current concepts in mucosal immunity. IV. How epithelial transport of IgA antibodies relates to host defense. Am J Physiol 1998; 274:G614-7.
19. Corthesy B, Kraehenbuhl JP. Antibody-mediated protection of mucosal surfaces. Curr Top Microbiol Immunol 1999; 236:93-111.
20. Bice DE, Muggenburg BA. Pulmonary immune memory: localized production of antibody in the lung after antigen challenge. Immunology 1996; 88:191-7.
21. Coro ES, Chang WL, Baumgarth N. Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J Immunol 2006; 176:4343-51.
22. Ishioka C, Yoshida A, Kimata H, Mikawa H. Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells. Clin Exp Immunol 1992; 87:504-8.
23. Litinskiy MB, Nardelli B, Hilbert DM, et al.DCs induce CD40- independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002; 3:822-9.
24. Castigli E, Wilson SA, Scott S, et al.TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 2005; 201:35-9.
25. Mackay F, Cancro MP. Travelling with the BAFF/BLyS family: are we there yet? Semin Immunol 2006; 18:261-2.
26. Welliver RC, Kaul TN, Putnam TI, Sun M, Riddlesberger K, Ogra PL. The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses. J Pediatr 1980; 96:808-13.
27. Bendelac A, Bonneville M, Kearney JF. Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 2001; 1:177-86.
28. Ray SK, Putterman C, Diamond B. Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease. Proc Natl Acad Sci U S A 1996; 93:2019-24.
29. Kim RJ, Kim HA, Park JB, et al.IL-4-induced AID expression and its relevance to IgA class switch recombination. Biochem Biophys Res Commun 2007; 361:398-403.
30. McIntyre TM, Kehry MR, Snapper CM. Novel in vitro model for highrate IgA class switching. J Immunol 1995; 154:3156-61.
31. Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992; 175:671-82.
32. Bekeredjian-Ding IB, Wagner M, Hornung V, et al.Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J Immunol 2005; 174:4043-50.
33. Woods A, Monneaux F, Soulas-Sprauel P, et al.Influenza virus-induced type I interferon leads to polyclonal B-cell activation but does not break down B-cell tolerance. J Virol 2007; 81:12525-34.
34. Harris DT, Schumacher MJ, Locascio J, et al.Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci U S A 1992; 89:10006-10.
35. Durandy A, De Saint BG, Lisowska-Grospierre B, et al.Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J Immunol 1995; 154:1560-8.
36. Velilla PA, Rugeles MT, Chougnet CA. Defective antigen-presenting cell function in human neonates. Clin Immunol 2006; 121:251-9.
37. Nardelli B, Belvedere O, Roschke V, et al.Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 2001; 97:198-204.
38. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1:135-45.
39. Jego G, Pascual V, Palucka AK, Banchereau J. Dendritic cells control B cell growth and differentiation. Curr Dir Autoimmun 2005; 8:124-39.
40. Ogra PL. Respiratory syncytial virus: the virus, the disease and the immune response. Paediatr Respir Rev 2004; 5(Suppl A):S119-26.
41. Jensen IP, Thisted E, Glikmann G, et al.Secretory IgM and IgA antibodies to respiratory syncytial virus in nasopharyngeal aspirates: a diagnostic supplement to antigen detection. Clin Diagn Virol 1997; 8:219-26.
42. Liu P, Jamaluddin M, Li K, Garofalo RP, Casola A, Brasier AR. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J Virol 2007; 81:1401-11.
43. Kato A, Truong-Tran AQ, Scott AL, Matsumoto K, Schleimer RP. Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism. J Immunol 2006; 177:7164-72.
44. Mackay F, Groom JR, Tangye SG. An important role for B-cell activation factor and B cells in the pathogenesis of Sjogren's syndrome. Curr Opin Rheumatol 2007; 19:406-13.
45. Groom JR, Fletcher CA, Walters SN, et al.BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med 2007; 204: 1959-71.
46. Gaipl US, Voll RE, Sheriff A, Franz S, Kalden JR, Herrmann M. Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev 2005; 4:189-94.
47. Russell MW, Reinholdt J, Kilian M. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgGmediated complement activation. Eur J Immunol 1989; 19:2243-9.
48. Heystek HC, Moulon C, Woltman AM, Garonne P, van Kooten C. Human immature dendritic cells efficiently bind and take up secretory IgA without the induction of maturation. J Immunol 2002; 168:102-7.
49. Honorio-Franca AC, Launay P, Carneiro-Sampaio MM, Monteiro RC. Colostral neutrophils express Fc alpha receptors (CD89) lacking gamma chain association and mediate noninflammatory properties of secretory IgA. J Leukoc Biol 2001; 69:289-96.
50. + T cell-dependent immunoglobulin A response to influenza infection in the absence of key cognate T-B interactions. J Exp Med 2003; 198:1011-21.